Clinical Trial Update: Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation [NA]

View source ↗

Summary

A clinical trial registry entry describing a study of intraoral photobiomodulation therapy to prevent oral mucositis in patients undergoing myeloablative alloge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Myeloablative Allogeneic Hematopoietic Cell Transplantation, Intraoral Photobiomodulation Therapy | NA | Status: RECRUITING